Abstract
The hormonal therapy (HT) is recommended for postmenopausal women primarily for the relief of vasomotor symptoms, treatment of vaginal atrophy, and prevention of osteoporosis. Despite these important benefits, only 35% to 40% of the women ever start HT, and many do not continue it. The reasons for discontinuation include resumption of bleeding, perceived risks of breast cancer, unacceptable side effects and the belief that treatment is no longer necessary. As a result, there is an increasing interest in the use of plant-derived estrogens, also known as phytoestrogens, which seem to be very promising. Isoflavones is the most investigated subgroup of phytoestrogens. They are attenuated estrogens and behave both in vivo and in vitro as agonists and antagonists. The highest concentrations of isoflavones are found primarily in soy beans. In this study, the effects of soy isoflavones on postmenopausal women were reviewed.
Keywords: Soy isoflavone, postmenopausal women, clinical review
Current Drug Therapy
Title: The Effects of Soy Isoflavones in Postmenopausal Women: Clinical Review
Volume: 1 Issue: 1
Author(s): Eliana A P. Nahas and Jorge Nahas-Neto
Affiliation:
Keywords: Soy isoflavone, postmenopausal women, clinical review
Abstract: The hormonal therapy (HT) is recommended for postmenopausal women primarily for the relief of vasomotor symptoms, treatment of vaginal atrophy, and prevention of osteoporosis. Despite these important benefits, only 35% to 40% of the women ever start HT, and many do not continue it. The reasons for discontinuation include resumption of bleeding, perceived risks of breast cancer, unacceptable side effects and the belief that treatment is no longer necessary. As a result, there is an increasing interest in the use of plant-derived estrogens, also known as phytoestrogens, which seem to be very promising. Isoflavones is the most investigated subgroup of phytoestrogens. They are attenuated estrogens and behave both in vivo and in vitro as agonists and antagonists. The highest concentrations of isoflavones are found primarily in soy beans. In this study, the effects of soy isoflavones on postmenopausal women were reviewed.
Export Options
About this article
Cite this article as:
Nahas A P. Eliana and Nahas-Neto Jorge, The Effects of Soy Isoflavones in Postmenopausal Women: Clinical Review, Current Drug Therapy 2006; 1 (1) . https://dx.doi.org/10.2174/157488506775268533
DOI https://dx.doi.org/10.2174/157488506775268533 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Determination of Isoflavones in Legumes by QuEChERS-Capillary Electrophoresis-Electrospray Ionization-Mass Spectrometry
Current Analytical Chemistry NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?
Current Medicinal Chemistry Editorial (Hot Topic: Translational Implications of Natural Agents)
Current Drug Targets Low Dose of Acacetin Promotes Breast Cancer MCF-7 Cells Proliferation Through the Activation of ERK/ PI3K /AKT and Cyclin Signaling Pathway
Recent Patents on Anti-Cancer Drug Discovery Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain
Current Pharmaceutical Design Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects
CNS & Neurological Disorders - Drug Targets Synthesis of Arylamino-1,3,5-triazines Functionalized with Alkylatin 2-chloroethylamine Fragments and Studies of their Cytotoxicity on the Breast Cancer MCF-7 Cell Line
Anti-Cancer Agents in Medicinal Chemistry Targeting miR-21 Induces Autophagy and Chemosensitivity of Leukemia Cells
Current Drug Targets Cyclin D1 Gene Silencing by siRNA in Ex Vivo Human Tissue Cultures
Current Drug Delivery Intercalators as Anticancer Drugs
Current Pharmaceutical Design Chitosan Nanoparticles as a Carrier for Indigofera intricata Plant Extract: Preparation, Characterization and Anticancer Activity
Current Cancer Therapy Reviews Tyrosine Kinases and Inflammatory Signalling
Current Molecular Medicine Vasoactive Intestinal Peptide Receptors: A Molecular Target in Breast and Lung Cancer
Current Pharmaceutical Design Antineoplastic Action of Growth Hormone-Releasing Hormone (GHRH) Antagonists
Recent Patents on Anti-Cancer Drug Discovery DNA Demethylation by TET Proteins: A Potential Therapeutic Target in Cancer
Epigenetic Diagnosis & Therapy (Discontinued) Phosphotyrosine Phosphatases in Cancer Diagnostic and Treatment
Recent Patents on DNA & Gene Sequences Hydrogen Sulfide and its Modulation in Arterial Hypertension and Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Metronomic Therapy for Multi Relapsed/Refractory Lymphoma. A Pilot Study
Current Angiogenesis (Discontinued) Serum of Blood Separation by Means of Dynamic Electrochromatography in a Centrifugal and Electromagnetic Gradient
Recent Patents on Biotechnology Another Brick in the Wall: Innate Lymphoid Cells of the Intestine
Current Immunology Reviews (Discontinued)